Highnoon Laboratories Limited (PSX:HINOON)

Pakistan flag Pakistan · Delayed Price · Currency is PKR
980.06
+1.29 (0.13%)
At close: Jun 19, 2026
Market Cap51.93B +9.6%
Revenue (ttm)28.20B +10.5%
Net Income4.22B +18.7%
EPS79.68 +18.7%
Shares Out 52.98M
PE Ratio12.30
Forward PE11.87
Dividend50.00 (5.10%)
Ex-Dividend DateApr 22, 2026
Volume23,510
Open984.90
Previous Close978.77
Day's Range966.00 - 991.89
52-Week Range755.56 - 1,241.00
Beta0.13
AnalystsStrong Buy
Price Target1,121.00 (+14.38%)
Earnings DateAug 26, 2026

About Highnoon Laboratories

Highnoon Laboratories Limited, together with its subsidiary, engages in the development, production, marketing, and distribution of pharmaceutical and allied consumer products in Pakistan, Afghanistan, the United Arab Emirates, Sri Lanka, France, Sudan, Cambodia, Kenya, Iraq, Dubai, Tanzania, and internationally. The company offers medicines in various drug forms and brands for allergy, anti-infective, cardiology, gastroenterology, metabolic, musculoskeletal, obstetrics and gynecology, pediatrics, respiratory, and urology therapeutic areas. It ... [Read more]

Industry Pharmaceuticals
Sector Healthcare
Founded 1984
Employees 2,563
Stock Exchange Pakistan Stock Exchange
Ticker Symbol HINOON
Full Company Profile

Financial Performance

In 2025, Highnoon Laboratories's revenue was 27.71 billion, an increase of 12.44% compared to the previous year's 24.64 billion. Earnings were 4.13 billion, an increase of 21.83%.

Financial Statements